Regulus Therapeutics
RGLS
#8662
Rank
โ‚น10.99 B
Marketcap
โ‚น165.97
Share price
-0.51%
Change (1 day)
-22.51%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -โ‚น3.89 Billion

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -โ‚น2.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น3.96 Billion56.97%
2023 -โ‚น2.52 Billion6.51%
2022 -โ‚น2.37 Billion2.53%
2021 -โ‚น2.31 Billion93.59%
2020 -โ‚น1.2 Billion-15.41%
2019 -โ‚น1.41 Billion-64.46%
2018 -โ‚น3.97 Billion-33.26%
2017 -โ‚น5.94 Billion-13.98%
2016 -โ‚น6.91 Billion44.77%
2015 -โ‚น4.77 Billion-1.63%
2014 -โ‚น4.85 Billion203.6%
2013 -โ‚น1.6 Billion8.65%
2012 -โ‚น1.47 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น375.97 B-9,611.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น679.47 B-17,290.56%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น163.06 B-4,225.54%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น892.58 B-22,682.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚น20.15 Billion 409.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น8.43 Billion 113.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น716.86 Billion 18,036.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น10.07 Billion 154.66%๐Ÿ‡บ๐Ÿ‡ธ USA